DR. NICHOLAS SCHULZ, MD
Osteopathic Medicine at Hot Metal St, Pittsburgh, PA
License number
Pennsylvania MD036843E
Category
Osteopathic Medicine
Type
Emergency Medicine
Address
Address
2 Hot Metal St, Pittsburgh, PA 15203
Phone
(412) 432-7424
Organization information
See more information about NICHOLAS SCHULZ at bizstanding.comNicholas Schulz MD
2 Hot Metal St, Pittsburgh, PA 15203
Industry:
Emergency Medicine, Internist
Phone:
(412) 432-7424 (Phone)
Nicholas Theodore Schulz
Professional information
Dr. Nicholas Schulz, Pittsburgh PA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
2 Hot Metal St STE 2, Pittsburgh 15203
(412) 432-7424 (Phone), (516) 799-0392 (Fax)
UNIVERSITY OF PITTSBURGH SHADYSIDE HOSPITAL
5230 Centre Ave, Pittsburgh 15232
(412) 623-2063 (Phone)
(412) 432-7424 (Phone), (516) 799-0392 (Fax)
UNIVERSITY OF PITTSBURGH SHADYSIDE HOSPITAL
5230 Centre Ave, Pittsburgh 15232
(412) 623-2063 (Phone)
Certifications:
Internal Medicine, 1985
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Pittsburgh / Main Campus
Graduated: 1982
University Hospital
University of Pittsburgh / Main Campus
Graduated: 1982
University Hospital
Methods For The Treatment Of Cancer
US Patent:
6150398, Nov 21, 2000
Filed:
Mar 20, 1996
Appl. No.:
8/618863
Inventors:
George F. Vande Woude - Berryville VA
Nicholas Schulz - Pittsburgh PA
Renping Zhou - Frederick MD
Ira Daar - Frederick MD
Marianne Oskarsson - Gaitherburg MD
Nicholas Schulz - Pittsburgh PA
Renping Zhou - Frederick MD
Ira Daar - Frederick MD
Marianne Oskarsson - Gaitherburg MD
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
and Human Services - Washington DC
International Classification:
C07D30514
US Classification:
514449
Abstract:
A pharmaceutical composition comprising an effective cancerous cell growth inhibiting amount of paclitaxel, or a paclitaxel derivative, and an effective cancerous cell growth inhibiting amount of an active agent which inhibits cancerous cell growth by exerting an effect on mammalian cell cycle during G. sub. 1 or S-phase of the cell division cycle to inhibit said cancerous cell growth and methods of using same.